The Federal Commission for the Protection against Sanitary Risk (COFREPRIS) has received an official letter from Sanofi-Aventis in Mexico in reference to a consumer complaint. An enquiry was opened following the complaint over the falsification of Plaquenil® 200 mg. The product was bubble-wrapped in a cardboard box of 20 tablets with lot number 9MXA006 and an expiry date of May 22.
The Sanofi-Aventis lab in Mexico has reported that an investigation and screening tests have revealed that the fake product does not contain hydroxychloroquine. The primary and secondary packaging also appears to have been tampered with: the printing is of poor quality and the font is a different color.
Source : www.gob.mxBack to previous